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Abstract The 20 S proteasome, found in eukaryotes and in the 
archaebacterium Thermoplasma acldophilum, forms the prote- 
olytic core of the 26 S proteasome which is the central protease 
of the non-lysosomal protein degradation pathway. Inhibitor stud- 
ies have indicated that the 20 S proteasome may be an unusual 
type of cysteine or serine protease and a recent study of the 
Thermoplasma [3 subunit has indicated that it carries the prote- 
olytic activity. We have attempted to obtain information on the 
nature of the active site by mutating the only cysteine, both 
histidines and two completely conserved aspartates in the 
archaebacterial complex as well as all serines of the/3 subunit, 
without decreasing the catalytic activity of the enzyme to any 
significant extent. Indeed, mutation of the conserved aspartate in 
the/3 subunit increased the activity of the proteasome threefold. 
We conclude that the proteasome is not a cysteine or serine 
protease. 
Key words: Proteasome; Proteolysis; Archaebacterium; 
Thermoplasma acidophilum 
1. Introduction 
The 26 S proteasome is the central protease of the ubiquitin- 
dependent pathway of protein degradation and has recently 
been shown to play an important role in MHC class I-linked 
antigen display. The core of the elongated 45 nm molecule is 
formed by the multicatalytic proteinase or 20 S proteasome, a 
barrel-shaped complex consisting of four seven-membered 
rings (reviewed in [1 3]). The rings are formed by 14 related but 
different subunits that fall into two families, o-type subunits 
forming the outer and ft-type subunits the inner rings of the 
complex. 20 S proteasomes, ubiquitous in eukaryotes, have also 
been found in the archaebacterium Thermoplasma acidophilum, 
where the complex is made up of only two proteins, ~ and ft, 
that have given their names to the eukaryotic subunit families. 
The role of the 26 S proteasome as the central enzyme of the 
non-lysosomal protein degradation pathway has generated 
considerable interest in the activity and regulation of the 20 S 
core complex. The latter was initially characterized from bovine 
pituitary as a multicatalytic protease with chymotrypsin-like, 
trypsin-like and peptidylglutamyl-peptide hydrolase activities 
[4], and has more recently been proposed to contain up to five 
different proteolytic components on the basis of inhibitor stud- 
ies [5]. Yet, despite intensive biochemical efforts, the nature of 
the proteasome active-site(s) remains unknown. The pH opti- 
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mum of the proteasome tends to be slightly basic, making it 
unlikely that the enzyme is an aspartic protease [6]. Similarly, 
no inhibition is observable by up to 10 mM EDTA, by other 
chelators, or by phosphoramidon, making it unlikely that the 
proteasome is a metal protease [6,7]. Inhibition experiments 
with various cysteine and serine protease inhibitors have 
yielded ambiguous results and have mostly been successful at 
high or very high inhibitor concentrations [5-9], generally in- 
hibiting only one of the different hydrolytic activities and some- 
times concurrently activating others [5]. On the basis of these 
experiments, the proteasome has been variously described as a 
serine or cysteine protease, with most recent opinions favoring 
an unusual type of serine protease [5 8]. 
The proteasome of Thermoplasma is much simpler than the 
eukaryotic proteasomes and has only a single, chymotrypsin- 
like activity, although experiments with denatured haemo- 
globin and insulin ft-chain show that the enzyme will hydrolyze 
virtually any peptide bond [10]. Both subunits of the Thermo- 
plasma proteasome have been cloned and overexpressed in 
Escherichia coli [11], opening the system up to easy genetic 
manipulation. In addition, since the Thermoplasma proteasome 
contains only one type of active site, mutations are considerably 
simpler to interpret than in eukaryotic proteasomes. We have 
therefore focused on this system in order to elucidate the nature 
of the proteasome active site. Although we have mutated resi- 
dues in both c~ and/3 subunits, we have focused on the ft 
subunits because these carry the active site: when expressed 
separately, ccsubunits assemble into 7-membered rings but re- 
main inactive, while ft subunits have a low but significant pro- 
teolytic activity even though they only form disordered aggre- 
gates [12]. 
In this communication we show that no histidine or cysteine 
residues are involved in the catalytic mechanism of the Thermo- 
plasma proteasome. In addition we also exclude all serine resi- 
dues of the ft subunit as well as several conserved serines of the 
subunit and the universally conserved aspartate (~D84, 
ftD51). Indeed, mutation of the latter in theft subunit increases 
the activity of the complex at least threefold. 
2. Materials and methods 
2.1. Materials 
Enzymes for DNA restriction and modification were obtained from 
New England Biolabs, Stratagene and USB. Oligonucleotides for in- 
verse PCR mutagenesis were synthesized on an Applied Biosystems 
380A DNA synthesizer. The synthetic fluorescent peptide Suc-Leu- 
Leu-VaI-Tyr-AMC (7-amido-4-methylcoumarin) was obtained from 
Bachem, Heidelberg. For screening and propagation of plasmids, we 
used the £ cob strain XL1-Blue [13]; for expression of wild-type and 
mutant proteasomes E. coli BL21 (DE3) [ 14]. All transformations were 
performed by electroporation using an E. coli Pulser from Bio-Rad 
Laboratories. 
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2.2. Construction of mutants 
Mutations were introduced by inverse PCR mutagenesis. Two plas- 
mids, pT7-5-,8-e and pT7-5-flA-~ [11], that contain the genes encoding 
the ¢z and fl subunits of the T. acidophilum proteasome, were used as 
templates. ,sA stands for a deletion of 21 5' nucleotides coding for the 
,8 pro-region. The PCR reactions and ligations were performed as 
described [15], but Pfu polymerase (Stratagene) was used in place of 
Taq polymerase, since this enzyme generates blunt ends which can be 
directly ligated. Incorporation of nucleotide xchanges was confirmed 
by DNA sequencing. 
2.3. Preparation of cell extracts for the primary screen 
Cultures of transformed BL21(DE3) cells were grown in SOB me- 
dium (100,ug/ml ampicillin) to an OD600 of 0.8 and induced with 1 mM 
isopropyl-,8-D-thiogalactopyranoside. Cells were harvested 5 h after 
induction, washed with 10 mM Tris-HC1, 100 mM NaC1, 1 mM EDTA, 
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Fig. 1. Alignment of proteasome subunit sequences showing the sites of mutation. The alignment is adapted from [21]; the sequences from rat (Rn), 
human (Hs) and Drosophila (Dm) represent the seven branches of c~ and fl subunits in eukaryotes. The numbering follows the Thermop&sma (Ta) 
sequences. Mutants are written in bold beneath the alignment. Except for subunits C7 and C10, where the cleavage site of the pro-peptide is not 
known, fl subunits are shown in their mature form. 
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pH 8.0, suspended in 300 pl 20 mM Tris-HC1, 1 mM EDTA, 1 mM 
NAN3, pH 7.5, resuspended, sonicated, heated to 85°C for 25 min and 
centrifuged at 12,000 x g for 10 rain. Supernatants were used for assays 
of the proteolytic activity. 
2.4. Purification of proteasomes 
The isolation and purification of recombinant wild-type proteasomes 
and selected mutant proteasomes were carried out as described previ- 
ously [16]. Protein concentrations were determined by HPLC-amino 
acid analysis, and samples were diluted to a final concentration of 
10pg/ml in 20 mM Tris-HCl, 1 mM EDTA, 1 mM NAN3, pH 7.5. 
2.5. Determ&ation of proteolytic activity and kinetic parameters 
In a primary screen, the proteolytic activities of mutant proteins were 
compared with wild-type and with a negative control (expression strain 
BL21(DE3)) using crude cell extracts and Suc-Leu-Leu-Val-Tyr-AMC 
in 20 mM Tris-HC1, 1 mM EDTA, 1 mM NAN3, pH 7.5, as a substrate. 
50 pl of a 400/,tM substrate solution and 50 pl of crude cell extract were 
incubated at 60°C for 60 min. The reaction was terminated with 1 ml 
of 100 mM monochloroacetate nd 100 mM sodium acetate, pH 4.3. 
Cleavage of the peptide substrate was monitored by measuring the 
release of AMC fluorometrically. For determination f specific activi- 
ties, 50 pl of purified protein solution (10/,tg/ml) and 50 ~1 of nine 
differentsubstrate concentrations (0.01 0.7 mM) were incubated for 15 
or 30 min at 60°C. Km and Vm,x were determined graphically by plotting 
V vs. V/[S] [17] and by direct linear plot [18], and a good agreement 
between the values was obtained. 
2.6. Gel-electrophoresis and Western blots 
Proteasomal subunits were seperated by Tricine-SDS-PAGE (16% 
polyacrylamide) [19], blotted onto nitrocellulose, and probed with anti- 
proteasome antibodies [20]. Assembly of mutant proteasomes was ex- 
amined on 5% polyacrylamide gels under non-denaturing conditions 
followed by Western blot analysis. 
3. Results 
3.1. Selection of mutation sites 
The active site residues in enzyme families are typically sur- 
rounded by blocks of conserved sequences, allowing the assign- 
ment of newly discovered sequences to an enzyme family and 
the identification of active site residues in families of enzymes 
not yet characterized biochemically. Such conserved regions 
containing amino acids with polar groups are not seen in pro- 
teasome subunits, a surprising feature of proteasome sequences 
being their strong divergence. The a-type subunits are distin- 
guished f romJ- type subunits by a highly conserved N-terminal 
extension of approximately 35 residues (Fig. 1) and by a com- 
pletely conserved RPxG motif. Otherwise, their sequence iden- 
tity is very low and limited to only five additional positions, 
L58, G80, D84, P153 and G166 (all numbers refer to the 
T. acidophilum subunits). E-type subunits are even more diver- 
gent and have only four invariant residues: G47, D51, G103 
and G128, of which G47, D51 and G128 are also present in 
a-type subunits. The hallmark of J - type subunits is a highly 
variable pro-sequence that may be anywhere from 4 to over 70 
residues long and which is cleaved off during proteasome as- 
sembly. 
In the absence of clear regions of sequence conservation, we 
selected residues that allowed us to address the hypothesis that 
the proteasome is an unusual serine or cysteine protease, and 
focussed in particular on the fl subunit. Thus, we mutated the 
single cysteine, aC151, the two histidines, fi l l28 andflH109, all 
serine residues in J (flS84, JS  112, JS  119, JS  126, JS  129, JS  131, 
iS140, JS143, iS160, JS167, flS169 and JS194), and two con- 
served serines in a (aS 16 and aS 167). In addition, we mutated 
the only entirely conserved potential nucleophile, aspartate 
Table 1 
Proteolytic assay of crude cell extracts 
Mutation Transformed plasmid % activity 
Controls 2 
fl-a (wild-type) 100 
fl A -ct 66 
fl subunit mutants 
Serine ~ alanine flAS84A-a 61 
flAS 112A-a 63 
flAS119A-~ 83 
flAS 126A-~ 102 
flAS129A-~ 14" 
flAS131A-at 80 
flAS 140A-c~ 123 
flAS 143A-c¢ 81 
flAS160A-c~ 52 
flAS167A-c~ 110 
flS 169A-a 30" 
flAS194A-c¢ 76 
flAS129A/S169A-0¢ 3" 
Histidine --~ alanine flAH28A-~ 105 
flAH 109A-c~ 134" 
Aspartate ~asparagine flD51N-a 295" 
--4 glutamate flD51E-a 185" 
a subunit mutants 
Serine --* alanine flA-aS 16A 56 
flA-~S 167A 55 
Cysteine --* valine fl-c~C 151V 76 
Aspartate --* asparagine flA-aD84N 9" 
Double (a + fl) mutants 
Aspartate ~ asparagine flD51N-~D84N 58 a 
Serine --* alanine flAS 129A-c~S 167A 35 
Activities were measured by incubating 50,ul of crude cell extracts with 
50/.tl of substrate solution (200 pM Suc-Leu-Leu-Val-Tyr-AMC) for 
60 min at 60°C. Values were not standardized for the concentration of
assembled proteasomes in the extracts. Measurements were made in 
triplicate and contain a standard error of up to 45%. Mutants are 
referred to by the wild-type amino acid, followed by the residue number 
and followed by the mutant amino acid. fl and c~ stand for the pro- 
teasomal genes according to their arrangement in the plasmid con- 
struct, and flA designates the gene deleted for the 21 nucleotides that 
code for the pro-region. 
"These mutants were selected for detailed analysis (Table 2). 
aD841JD51, in both subunits separately and jointly. All resi- 
dues were mutated to alanine, except for aC151 which was 
mutated to valine because it was located in a predicted J-strand 
[21], and for the two aspartates aD84 and JD5 I  that were 
mutated to asparagine and glutamate to preserve some of the 
structural and electrostatic properties. 
3.2. Construction of pSA-o~ mutants 
During initial screens we found that some mutations de- 
creased the post-translational processing of the fl pro-region 
and reduced the amount of assembled proteasomes that could 
be recovered. This was particularly conspicuous in the case of 
flS129A, where the amount of processed fl subunit was signifi- 
cantly reduced and of proteasomes recovered was less than 10% 
of that recovered from a clone containing a fl gene deleted for 
the 21 5' nucleotides that code for the pro-region (flAS129A-a). 
Only processed J subunits appear as components of intact 
proteasomes and the efficient removal of the pro-region might 
be a basic requirement for proteasome assembly. We did not 
investigate the effects of mutation on post-translational proc- 
essing in more detail but constructed the mutants in a flA-a 
plasmid in order to overcome problems due to insufficient 
yield. 
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3.3. Screening for mutants with decreased activity 
Based on earlier publications which had classified the Ther- 
moplasma proteasome as chymotryptic [6] we screened mutant 
proteins for proteolytic activity using the chymotryptic sub- 
strate Suc-Leu-Leu-Val-Tyr-AMC. Crude cell extracts of un- 
transformed E. co# BL21(DE3) served as a negative control. 
Table 1 summarizes activity data obtained with crude cell ex- 
tracts expressed as a percentage of wild-type proteasome activ- 
ity. In this initial screen, protein concentrations were estimated 
using Western blot analyses (data not shown), and the expres- 
sion of mutant proteasomal subunits was found to be very 
similar to that of wild-type subunits, but the amount of assem- 
bled proteasomes was conspicuously low in some mutants de- 
spite the use offlA constructs. The four mutants with the lowest 
amounts of assembled proteasomes were, in order of increasing 
yield: flA-otD84N <flAS 129A/S 169A-c~ <flAS 129A-c~ < flD51N- 
c~D84N, consistent with their low activity in proteolytic assays 
of crude cell extracts (Table 1). Surprisingly, mutation of the 
residue homologous to flS129 in a, aS167, relieved the pheno- 
type offlAS129A, yielding an increased activity for the double 
mutant. A similar effect was found for the mutant flA-aD84N 
whose phenotype was relieved by mutation of the homologous 
residue in fl, flD51. 
Most other mutants characterized in the initial screen dis- 
pl'ayed activities equal to or approaching that of the wild-type 
enzyme within the error of the assay. Eight mutants, including 
the seven which showed less than 30% or more than 130% of 
wild-type activity (Table 1) were subjected to protein purifica- 
tion and detailed kinetic analysis. 
3.4. Specific activities of selected mutants 
Specific activity measurements of purified proteins revealed 
much less dramatic deviations from wild-type values (Table 2) 
than anticipated from the results in Table 1. Thus, the four 
mutants with the lowest activity in Table 1, flAS129A-c~, 
flS169A-c~, flAS129A/S169A-ct, and flA-aD84N, had 75, 55, 35 
and 70% of wild-type activity, respectively. These results are 
consistent with our observation that unusally low concentra- 
tions of proteasomes were present in the cell extracts of these 
mutants. Since the mutation of residues involved in the catalytic 
mechanism should result in a loss of proteolytic activity, or at 
Table 2 
Kinetic parameters of Suc-Leu-Leu-Val-Tyr-AMC hydrolysis 
Specific 
activities 
(%) 
Kinetic parameters 
Km kc~t kc,JKm 
q2M) (10-3. s-l) (M-I.s I) 
fl-a wild-type 100 85 + 14 30 _+ 2 353 
Mutants 
flAS129A-a 75 125 _+ 41 26 _+ 7 208 
flS169A-a 55 75 + 17 17 _+ 3 227 
flAS129A/S169A-a 35 80 _+ 20 10 _+ 2 125 
flD51N-c~ 330 100 _+ 32 99 + 13 990 
flD51E-cc 140 220 + 60 97 + 16 441 
flD51N-~D84N 190 130 + 21 65 + 12 500 
flA-c~D84N 70 70 + 16 20 + 2 286 
flAH109A-c~ 140 65 + 10 37 + 3 569 
Specific activities were obtained by incubating 0.5 Bg of purified protein 
with different substrate concentrations, as described in section 2.5. 
Values contain a standard error of 20-25%. Kinetic parameters were 
determined by direct linear plot [18]. For calculation of kca t, we assumed 
14 active sites per particle. 
oxyanion binding site 
1 a mainchain-NH 
lb mainchain-NH, Asn -NH 2 
2 mainchain-NH, Gln-NH2 
3ac Zn 2+, Arg+-NH 2
3b Zn 2+, His+-NH, Tyr-OH 
4 AspH, Tyr-0 
(lOl ) 
RV/C 
nucleophile Y 
1 Ser-O (<- His <- Asp-) 
2 Cys-S (<- His) 
3ab OH- (<- Glu-) 
3c OH- (<- Asp-) 
4 OH- (<- Asp-) 
H 
proton  donor  
1 His+-NH 
2 His+-NH 
3ab GluH 
3c Lys+-NH3 
4 AspH 
Fig. 2. General reaction mechanism of proteases. 1. Serine proteases: 
(a) chymotrypsin family, (b) subtilisin family. 2. Cysteine proteases. 
3. Metallo-proteases: (a) carboxypeptidase A, (b) thermolysin, (c) leuc- 
ine aminopeptidase. 4. Aspartic proteases. 
least in a severe decrease, we conclude that none of the residues 
mutated in this study participate in catalysis. Thus, we conclude 
that the proteasome is not a cysteine or serine protease. 
Mutations in two residues, flS129 and flD51, appeared to 
cause an increase in Kin, suggesting an effect of the mutation 
on substrate binding or accessibility. The effect offlS129A was 
not observed in the double mutant flAS129AlS169A-a, the re- 
duced specific activity of which was mainly due to a decrease 
in Vm,x. Decreased Vmax values were also found for mutants 
flS169A-a and flA-aD84N. Surprisingly, some mutations ap- 
peared to cause an increase of  Vmax. Mutation of flD51, both 
to asparagine and to glutamate, resulted in a 3-fold increase of 
Vmax. Simultaneous mutation of the homologous aspartate in 
c~ was found to reduce this increase by about 30%, consistent 
with its effect in mutant flA-aD84N where the Vma x is reduced 
by 30% relative to wild-type. A minor increase in Vrnax was  also 
observed in the histidine mutant flAH109A-a. In all four mu- 
tants with elevated Vmax, the specific activity was higher than 
that of wild-type, even though in at least two mutants the Km 
values had also increased. 
The kinetic parameters that we measured in our proteasome 
preparations are significantly different from the ones reported 
by Dahlmann et al. [6] even when we raised the temperature of 
the assay to 91°C as in the other study. The reasons for this 
discrepancy are unclear but we note that proteasomes purified 
by the method of Dahlmann et al. also differ from the ones 
purified by our procedure in other important properties, such 
as their dissociation and reconstitution [22]. 
4. Discussion 
Proteases have been classified into four families by the nature 
of the nucleophile attacking the peptide bond (Fig. 2) (reviewed 
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in [23]). Best studied are the serine proteases (trypsin, chymot- 
rypsin, thrombin, subtilisin) in which the nucleophilic attack is 
made by the hydroxyl group of an active site serine, the proton 
of which is stripped by a charge-relay s stem involving a histid- 
ine and an aspartate r sidue. Since the structures of the chymot- 
rypsin-like proteases are unrelated to the structure of subtilisin, 
it is believed that this charge-relay s stem has evolved at least 
twice independently. In a related group of enzymes, the fl- 
lactamases, the role of the histidine is performed by a triad of 
serine, lysine and glutamate, while the role of the aspartate is
assumed by an asparagine [24]. In cysteine proteases (papain, 
calpain), the nucleophilic attack is made by the thiol group of 
an active site cysteine, the proton of which is stripped by a 
histidine in what appears to be an analogue of the serine pro- 
tease catalytic triad. It is not clear which residue assumes the 
role of the aspartate in the triad but an asparagine (papain) or 
a carboxyl group (viral endopeptidases) have been proposed. 
In metallo-proteases, the nucleophilic attack is made by the 
carboxyl group of a glutamate (carboxypeptidase, thermolysin, 
elastase) or aspartate (leucine aminopeptidase) via a bound 
water molecule, while the metal ion(s), typically Zn 2÷, form the 
oxyanion binding site. In aspartic proteases (pepsin, renin, HIV 
protease), finally, the nucleophilic attack is also made by the 
carboxyl group of an aspartate via a bound water molecule, 
while a second aspartate with a shifted pK functions as the 
general acid. The aspartic proteases are generally monomers 
built of two domains with approximate twofold symmetry 
in which the catalytic aspartates occupy equivalent positions, 
but homodimeric aspartic proteases are also found in retro- 
viruses and are believed to represent an ancestral form of the 
enzyme. 
Because proteasomes could not be assigned to any of these 
four families on the basis of sequence similarity or patterns of 
conserved residues [25,26], aclassification was attempted on the 
basis of inhibitor studies [5-8]. From its basic pH optimum [6] 
and its insensitivity o pepstatin [7], it was concluded that the 
proteasome is not an aspartic protease. From its insensitivity 
towards chelators and phosphoramidon [6,7] it was also con- 
cluded that it is not a metal protease. The inhibitors found to 
be effective were mainly serine or cysteine protease inhibitors 
although the results were generally inconclusive, as the inhib- 
itors were required in high concentrations [5-9]. The interpreta- 
tion of their effect was further obscured by the fact that the 
eukaryotic proteasome contains multiple proteolytic activities 
and inhibitors often inhibited only one of these [5]. The 
two inhibitor classes that proved to be of some prom- 
ise were coumarins [5 8], which are serine protease inhibi- 
tors, and peptide aldehydes [5,9], which act against cysteine 
proteases. On the basis of these results it was proposed that 
the proteasome is an unusual form of serine or cysteine pro- 
tease. 
We have addressed this hypothesis by generating a large 
number of proteasome mutants in Thermoplasma, because in 
this organism the proteasome contains only one type of active 
site and results can therefore be interpreted more easily. We 
have mutated the only cysteine and both histidines in the com- 
plex and have found that these mutants had activities compara- 
ble to wild-type. We can thus rigourously exclude the possibility 
that the proteasome is a cysteine protease. Furthermore, we 
have mutated individually all serine residues in the fl subunit 
without obtaining significant inactivation. Since the Thermo- 
plasma fl subunit retains residual proteolytic activity when ex- 
pressed separately, while the ~ subunit assembles into rings but 
remains completely inactive [12], we can essentially exclude the 
possibility that the proteasome is a serine protease. Certainly 
we can exclude the possibility that it is a serine protease of the 
type containing a Ser-His-Asp catalytic triad on the basis of the 
histidine mutants. As a final hypothesis, we explored the possi- 
bility that the proteasome is related to aspartic proteases and 
that the ~ and fl subunits are analogous to the two domains of 
these enzymes. In this hypothesis, the universally conserved 
aspartates ~D84 and flD51 would correspond to the catalytic 
residues of the aspartic proteases. To our surprise, mutation of 
D84 in c~ subunits did not significantly affect activity, while 
mutation of D51 in fl subunits enhanced activity threefold, 
clearly showing that the proteasome is also not related to aspar- 
tic proteases. While we are unable to rationalize the phenotype 
of the flD51 mutants at this point, the fact that two of fif- 
teen sites mutated in fl resulted in an increased VVma x suggests 
that the proteasome has evolved to operate at a lower 
catalytic efficiency than is achievable with this type of active 
site. 
In conclusion, we have shown that the proteasome is not a 
serine or cysteine protease and that it is not related mechanisti- 
cally to the aspartic proteases. Combined with the complete 
lack of sequence relatedness between proteasomes and other 
proteases and with the inconclusive nature of most inhibitor 
studies, the results presented here indicate that the proteasome 
is a novel type of protease. 
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